Neuroendocrinology of autoimmunity
- PMID: 12498103
- DOI: 10.1016/s0074-7742(02)52008-0
Neuroendocrinology of autoimmunity
Abstract
The HPA axis is fundamental for long-term survival and protection from the ravages of autoimmune disease. Continuing investigations suggest that the hypothesis linking susceptibility to autoimmune disease and a hyporesponsive HPA axis is somewhat simplistic. Instead, data from a number of different human diseases and from preclinical studies in a variety of models have suggested a more complicated picture. Alterations in the diurnal rhythms of ACTH, cortisol, and immune parameters appear to be linked to severity of disease. The use of low doses of steroids timed to target disrupted diurnal immune system changes in patients with RA may reduce the unfortunate side effects of long-term steroid use. Studies in cancer patients have related alterations in diurnal cortisol to survival. Whether differences in individual cortisol profiles are predictive of a deterioration in symptoms of autoimmune disease remains to be established. Responsiveness of the HPA axis to subtle challenges such as the dexamethasone suppression test and the related dexamethasone-CRF test suggest that there are different sub-populations of patients with RA and MS and these may have confounded earlier, apparently contradictory, studies. These different responses may be related to the severity of the disease. That these HPA axis differences can be altered beneficially through the use of antidepressants, as has been shown in MS, may impact on future health care strategies. However, reports of negative developments in arthritis associated with SSRI use suggest that the SSRIs may be unsuitable under some circumstances. The link of behavioral differences to alterations in neurotransmitter changes associated with disease is intriguing and opens new avenues of research. These future studies will require input from neuroscientists, neuroendocrinologists, psychologists, and immunologists working with the clinical specialties already involved in treating patients with autoimmune disease. These multidisciplinary studies reflecting the increased importance of hormonal and neurotransmitter involvement with the immune system hold great promise for the future.
Similar articles
-
Neuroendocrine function and chronic inflammatory stress.Exp Physiol. 2002 Sep;87(5):519-25. doi: 10.1113/eph8702411. Exp Physiol. 2002. PMID: 12481925 Review.
-
Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.Psychoneuroendocrinology. 2014 Jul;45:87-95. doi: 10.1016/j.psyneuen.2014.03.012. Epub 2014 Apr 2. Psychoneuroendocrinology. 2014. PMID: 24845180 Clinical Trial.
-
Neuroendocrine-immune (NEI) circuitry from neuron-glial interactions to function: Focus on gender and HPA-HPG interactions on early programming of the NEI system.Immunol Cell Biol. 2001 Aug;79(4):400-17. doi: 10.1046/j.1440-1711.2001.01030.x. Immunol Cell Biol. 2001. PMID: 11488988 Review.
-
Hypothalamo-pituitary-adrenal axis and chronic immune activation.Ann N Y Acad Sci. 2003 May;992:99-106. doi: 10.1111/j.1749-6632.2003.tb03141.x. Ann N Y Acad Sci. 2003. PMID: 12794050 Review.
-
Neuroendocrine dysfunction in Sjogren's syndrome.Neuroimmunomodulation. 2008;15(1):37-45. doi: 10.1159/000135622. Epub 2008 Jul 29. Neuroimmunomodulation. 2008. PMID: 18667798 Review.
Cited by
-
Effects of cranberry powder on biomarkers of oxidative stress and glucose control in db/db mice.Nutr Res Pract. 2013 Dec;7(6):430-8. doi: 10.4162/nrp.2013.7.6.430. Epub 2013 Nov 29. Nutr Res Pract. 2013. PMID: 24353827 Free PMC article.
-
Cardiovascular, hormonal, and emotional responses to the TSST in relation to sex and menstrual cycle phase.Psychophysiology. 2010 May 1;47(3):550-9. doi: 10.1111/j.1469-8986.2009.00961.x. Epub 2010 Jan 11. Psychophysiology. 2010. PMID: 20070572 Free PMC article.
-
Characterization of thymocyte phenotypic alterations induced by long-lasting beta-adrenoceptor blockade in vivo and its effects on thymocyte proliferation and apoptosis.Mol Cell Biochem. 2006 Apr;285(1-2):87-99. doi: 10.1007/s11010-005-9059-5. Epub 2006 Feb 14. Mol Cell Biochem. 2006. PMID: 16477376
-
Adverse effects of chronic opioid therapy for chronic musculoskeletal pain.Nat Rev Rheumatol. 2010 Apr;6(4):191-7. doi: 10.1038/nrrheum.2010.24. Nat Rev Rheumatol. 2010. PMID: 20357788 Review.
-
New insights into cytokine gene expression in the rat hypothalamus following endotoxin challenge.Neurochem Res. 2010 Jun;35(6):909-11. doi: 10.1007/s11064-009-0071-0. Epub 2009 Oct 9. Neurochem Res. 2010. PMID: 19816771